Autolus Therapeutics (AUTL) Receivables - Other (2017 - 2025)
Autolus Therapeutics posted quarterly Receivables - Other of $915000.0 for Q4 2025, up 86.35% year-on-year from $491000.0 in Q4 2024, and down 2.24% on a QoQ basis from $936000.0 in Q3 2025.
Autolus Therapeutics (AUTL) has 8 years of Receivables - Other data on file, last reported at $915000.0 in Q4 2025.
- For the quarter ending Q4 2025, Receivables - Other rose 86.35% year-over-year to $915000.0; the trailing twelve-month figure through Dec 2025 stood at $915000.0 (up 86.35% YoY), and the FY2025 full-year result was $915000.0, up 86.35% from the prior year.
- Receivables - Other for Q4 2025 stood at $915000.0, down from $936000.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $2.4 million in Q3 2023 and bottomed at $384000.0 in Q4 2021.
- The 5-year median for Receivables - Other is $700500.0 (2024), against an average of $867750.0.
- The widest annual swing landed in 2022, when Receivables - Other surged 273.7%; it then plunged 74.63% in 2024.
- A 5-year view of Receivables - Other shows it stood at $384000.0 in 2021, then soared by 273.7% to $1.4 million in 2022, then sank by 64.04% to $516000.0 in 2023, then decreased by 4.84% to $491000.0 in 2024, then surged by 86.35% to $915000.0 in 2025.
- The last three Receivables - Other figures came in at $915000.0 (Q4 2025), $936000.0 (Q3 2025), and $665000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Autolus Therapeutics | - | - | -1.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 915,000.00 |
| Dec 31, 2025 | 915,000.00 |
| Sep 30, 2025 | 936,000.00 |
| Sep 30, 2025 | 936,000.00 |
| Jun 30, 2025 | 665,000.00 |
| Jun 30, 2025 | 665,000.00 |
| Mar 31, 2025 | 423,000.00 |
| Mar 31, 2025 | 423,000.00 |
| Dec 31, 2024 | 491,000.00 |
| Dec 31, 2024 | 491,000.00 |
| Sep 30, 2024 | 598,000.00 |
| Sep 30, 2024 | 598,000.00 |
| Jun 30, 2024 | 957,000.00 |
| Jun 30, 2024 | 957,000.00 |
| Mar 31, 2024 | 736,000.00 |
| Mar 31, 2024 | 736,000.00 |
| Dec 31, 2023 | 516,000.00 |
| Dec 31, 2023 | 516,000.00 |
| Sep 30, 2023 | 2.36 Mn |
| Sep 30, 2023 | 2.36 Mn |
| Dec 31, 2022 | 1.44 Mn |
| Dec 31, 2022 | 1.44 Mn |
| Dec 31, 2021 | 384,000.00 |
| Dec 31, 2021 | 384,000.00 |
| Dec 31, 2020 | 199,000.00 |
| Dec 31, 2020 | 199,000.00 |
| Dec 31, 2018 | 661,000.00 |
| Dec 31, 2018 | 661,000.00 |
| Sep 30, 2018 | 678,000.00 |
| Sep 30, 2018 | 678,000.00 |
| Mar 31, 2018 | -1,000.00 |
| Mar 31, 2018 | -1,000.00 |
| Sep 30, 2017 | 135,000.00 |
| Sep 30, 2017 | 135,000.00 |